Knockdown of PKM2 suppresses tumor growth and invasion in lung adenocarcinoma

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 24574-24587

  Sun, Hong ^a   Zhu, Anyou ^a   Zhang, Lunjun ^a   Zhang, Jie ^b   Zhong, Zhengrong ^a   Wang, Fengchao ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Fatty acid synthesis; Glycolysis; Invasion; Lung adenocarcinoma; Pyruvate kinase M2

Indexed keywords

GELATINASE A; GLUCOSE TRANSPORTER 1; PYRUVATE KINASE; PYRUVATE KINASE M2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; CARRIER PROTEIN; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING; ADENOCARCINOMA; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID HORMONES;

EID: 84945207764     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161024574     Document Type: Article

References (27)

1. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The Next Generation. Cell 2011, 5, 646-674
2. Bensinger, S.J.; Christofk, H.R. New aspects of the Warburg effect in cancer cell biology. Semin. Cells. Dev. Biol. 2012, 23, 352-361
3. Carins, R.A.; Harris, I.S.; Mak, T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11, 85-95
4. Semenza, G.L. Hypoxia inducible factor 1 and cancer pathogenesis. IUBMB Life 2008, 60, 591-597
5. EI Mjiyad, N.; Caro-Maldonado, A.; Ramirez-Peinado, S.; Munoz-Pinedo, C. Sugar-free approaches to cancer cell killing. Oncogene 2011, 30, 253-264
6. Koppenol, W.H.; Bounds, P.L.; Dang, C.V. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11, 325-337
7. Sheng, S.L.; Liu, J.J.; Dai, Y.H.; Sun, X.G.; Xiong, X.P.; Huang, G. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J. 2012, 279, 3898-3910
8. Rui-hui, X.U.; Helene, P.; Yan, Z.; Jennifer, S.C.; Li, F.; Kapil, N.; Keating, M.G.; Huang, P. Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005, 65, 613-621
9. Zhou, X.; Chen, R.H.; Xie, W.H.; Ni, Y.C.; Liu, J.J.; Huang, G. Relationship between 18F-FDG accumulation and lactate dehydrogenase A expression in lung adenocarcinomas. J. Nucl. Med. 2014, 55, 1766-1771
10. Ferguson, E.C.; Rathmell, J.C. New roles for pyruvate kinase M2: Working out the Warburg effect. Trends Biochem. Sci. 2008, 33, 359-362
11. Dombrauckas, J.D.; Santarsiero, B.D.; Mesecar, A.D. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005, 44, 9417-9429
12. Noguchi, T.; Inoue, H.; Tanaka, T. The M1-and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem. 1986, 261, 13807-13812
13. Christofk, H.R.; Vander Heiden, M.G.; Harris, M.H.; Ramanathan, A.; Gerszten, R.E.; Wei, R.; Fleming, M.D.; Schreiber, S.L.; Cantley, L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452, 230-233
14. Wong, N.; De Melo, J.; Tang, D. PKM2, a central point of regulation in cancer metabolism. Int. J. Cell Biol. 2013, 2013, doi:10.1155/2013/242513
15. Bonuccelli, G.; Whitaker-Menezes, D.; Castello-Cros, R.; Pavlides, S.; Pestell, R.G.; Fatatis, A.; Witkiewicz, A.K.; Vander Heiden, M.G.; Migneco, G.; Chiavarina, B.; et al. The reverse Warburg effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 2010, 9, 1960-1971
16. Hathurusinghe, H.R.; Coonetilleke, K.S.; Siriwardena, A.K. Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann. Surg. Oncol. 2007, 14, 2714-2720
17. Zhou, C.F.; Li, X.B.; Sun, H.; Zhang, B.; Han, Y.S.; Jiang, Y.; Wu, G.H. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells. IUBMB Life 2012, 64, 775-782
18. Watanabe, Y. TNM classification for lung cancer. Ann. Thorac. Cardiovasc. Surg. 2012, 9, 343-350
19. Yang, W.; Xia, Y.; Hawke, D.; Li, X.; Liang, J.; Xing, D.; Lu, Z. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012, 150, 685-696
20. Vesselle, H.; Freeman, J.D.; Wiens, L.; Stern, J.; Nguyen, H.Q.; Hawes, S.E.; Wood, D.E. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: New contrary data on prognostic role. Clin. Cancer Res. 2007, 13, 3105-3106
21. Starska, K.; Forma, E.; Jóźwiak, P.; Bryś, M.; Lewy-Trenda, I.; Brzezińska-Błaszczyk, E.; Krześlak, A. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis. Tumour Biol. 2014, 36, 2309-2321
22. Miao, P.; Sheng, S.; Sun, X.; Liu, J.; Huang, G. Lactate dehydrogenase A in cancer: A promising target for diagnosis and therapy. IUBMB Life 2013, 65, 904-910
23. Yang, W.; Zheng, Y.; Xia, Y.; Ji, H.; Chen, X.; Guo, F.; Lu, Z. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 2012, 14, 1295-1304
24. Yang, W.; Xia, Y.; Cao, Y.; Zheng, Y.; Bu, W.; Zhang, L.; You, M.J.; Koh, M.Y.; Cote, G.; Aldape, K. EGFR-induced and PKC monoubiquitylation-dependent NF-B activation up-regulates PKM2 expression and promotes tumorigenesis. Mol. Cell 2012, 48, 771-784
25. Beckner, M.E.; Fellows-Mayle, W.; Zhang, Z.; Agostino, N.R.; Kant, J.A.; Day, B.W.; Pollack, I.F. Identification of ATP citrate lyaseas a positive regulator of glycolytic function in glioblastomas. Int. J. Cancer 2010, 126, 2282-2295
26. Hatzivassiliou, G.; Zhao, F.P.; Bauer, D.E.; Andreadis, C.; Shaw, A.N.; Dhanak, D.;Hingorani, S.R.; Tuveson, D.A.; Thompson, C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8, 311-321
27. Graph Pad Prism, version 5.00; Software for Biostatistics; GraphPad software: San Diego, CA, USA, 2007